MedMira Inc. (TSXV: MIR)

Market Cap	57.66M
Revenue (ttm)	383.32K
Net Income (ttm)	-3.11M
Shares Out	720.81M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	146,080
Open	0.0800
Previous Close	0.0800
Day's Range	0.0800 - 0.0800
52-Week Range	0.0700 - 0.1400
Beta	10.66
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 28, 2024

About MedMira

MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and syphilis;...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1993
• Employees: 52
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: MIR

Financial Performance

In 2023, MedMira's revenue was 432,529, a decrease of -54.57% compared to the previous year's 952,127. Losses were -2.68 million, 46.1% more than in 2022.